COMP <GO>
OHI vs JPM // FREE CASH FLOW YIELD
Omega Healthcare Investors Inc. (NYSE) VS. JPMorgan Chase & Co. (NYSE) • 15-METRIC TALLY: OHI 6
— JPM 8
▲ FREE CASH FLOW YIELD LEADER: OHI
LAST: $46.98 (+0.30%) • MKT CAP: $14.19B
fcf-yield
5.81%
LAST: $337.04 (-1.90%) • MKT CAP: $895.92B
fcf-yield
-18.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OHI VS. JPM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OHI | JPM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.00% | 17.37% | -17.37 | JPM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 9.7x | +85.33 | JPM | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.81% | -18.14% | +23.95 | OHI | /fcf-yield <GO> |
| Operating Margin | 0.10% | 42.07% | -41.97 | JPM | /operating-margins <GO> |
| Net Profit Margin | 0.10% | 32.63% | -32.53 | JPM | /net-margins <GO> |
| Revenue Growth (YoY) | 13.20% | 13.53% | -0.33 | JPM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.50% | 1.96% | +3.54 | OHI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.89 | 0.37 | +2.52 | OHI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 2/9 | +7.00 | OHI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 4.84% | +2.36 | JPM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 49.0 | +7.75 | OHI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.00 | +0.08 | OHI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 13.6x | +126.43 | JPM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.19B | $895.92B | -$881.72B | JPM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OHI REV | JPM REV | OHI GROSS % | JPM GROSS % | OHI FCF | JPM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.19B | $182.45B | 44.0% | — | $825.0M | -$147.78B |
| FY 2024 | $1.05B | $177.56B | 44.0% | — | $702.1M | -$42.01B |
| FY 2023 | $949.7M | $158.10B | 44.0% | — | $575.0M | $12.97B |
| FY 2022 | — | $128.69B | — | — | — | $107.12B |
| FY 2021 | — | $121.65B | — | — | — | $78.08B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OHI // BETA 1.08
JPM // BETA 1.00